サマリー

欧州のPOCT市場 2023-2027
欧州のPOCT市場は、2022-2027年に5億7,508万米ドルの成長が予測され、予測期間中のCAGRは7.75%で加速すると予測されています。当レポートでは、欧州のPOCT市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、高齢者人口の増加、個別化医療への注目の高まり、医療業界における自動診断機器の採用拡大などが牽引しています。
Technavio社の調査レポートでは、欧州のPOCT市場を以下のように分類しています：
タイプ別
- OTC検査
- 処方箋に基づく検査
用途別
- 血糖値検査
- 感染症検査
- 心臓マーカー検査
- 妊娠・不妊検査
- その他
地域別
- 欧州
本調査では、今後数年間における欧州のPOCT市場の成長を促進する主な理由の一つとして、従来の検査方法から迅速診断検査へのシフトを挙げている。また、診断の技術的進歩や低価格のテストストリップの導入に注力する動きが活発化していることも、同市場における大きな需要につながる。
欧州のPOCT市場に関するレポートは以下の分野をカバーしています：
- 欧州のPOCT市場規模
- 欧州のPOCT市場予測
- 欧州のPOCT市場産業分析
堅牢なベンダー分析は、顧客が市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、欧州のPOCT市場をリードするいくつかのベンダーの詳細な分析を提供しています。Menarini Industrie Farmaceutiche Riunite Srl、Abbott Laboratories、ACON Laboratories Inc.、Becton Dickinson and Co.、bioMerieux SA、Chembio Diagnostics Inc.、Danaher Corp.、F. Hoffmann La Roche Ltd.、Fluxergy Inc、ジョンソン・アンド・ジョンソン・サービス社、ライフスキャンIPホールディングス社、ノヴァ・バイオメディカル社、オラシュア・テクノロジーズ社、PHCホールディングス社、Sdバイオセンサー社、シーメンス社、シノケア社、シスメックス社、サーモフィッシャーサイエンティフィック社、トリニティ・バイオテック社。また、欧州のPOCT市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/europe-POCT-market-analysis](https://www.technavio.com/report/europe-poct-market-analysis)
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Country Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
• 4 Historic Market Size
o 4.1 POCT market in Europe 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on poct market in Europe 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 22: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 25: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 26: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 27: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 28: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 29: Chart on Type - Market share 2022-2027 (%)
o Exhibit 30: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 31: Chart on Comparison by Type
o Exhibit 32: Data Table on Comparison by Type
o 6.3 OTC testing - Market size and forecast 2022-2027
o Exhibit 33: Chart on OTC testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 34: Data Table on OTC testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Chart on OTC testing - Year-over-year growth 2022-2027 (%)
o Exhibit 36: Data Table on OTC testing - Year-over-year growth 2022-2027 (%)
o 6.4 Prescription-based testing - Market size and forecast 2022-2027
o Exhibit 37: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 38: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%)
o Exhibit 40: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 41: Market opportunity by Type ($ million)
o Exhibit 42: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 43: Chart on Application - Market share 2022-2027 (%)
o Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 45: Chart on Comparison by Application
o Exhibit 46: Data Table on Comparison by Application
o 7.3 Blood glucose testing - Market size and forecast 2022-2027
o Exhibit 47: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%)
o 7.4 Infectious diseases testing - Market size and forecast 2022-2027
o Exhibit 51: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
o 7.5 Cardiac markers testing - Market size and forecast 2022-2027
o Exhibit 55: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
o 7.6 Pregnancy and fertility testing - Market size and forecast 2022-2027
o Exhibit 59: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
o 7.7 Others - Market size and forecast 2022-2027
o Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Application
o Exhibit 67: Market opportunity by Application ($ million)
o Exhibit 68: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 70: Chart on Market share By Geographical Landscape - 2022-2027 (%)
o Exhibit 71: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 72: Chart on Geographic comparison
o Exhibit 73: Data Table on Geographic comparison
o 9.3 Germany - Market size and forecast 2022-2027
o Exhibit 74: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.4 France - Market size and forecast 2022-2027
o Exhibit 78: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 81: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.5 Italy - Market size and forecast 2022-2027
o Exhibit 82: Chart on Italy - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Chart on Italy - Year-over-year growth 2022-2027 (%)
o Exhibit 85: Data Table on Italy - Year-over-year growth 2022-2027 (%)
o 9.6 UK - Market size and forecast 2022-2027
o Exhibit 86: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 89: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.7 Rest of Europe - Market size and forecast 2022-2027
o Exhibit 90: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 93: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
o 9.8 Market opportunity By Geographical Landscape
o Exhibit 94: Market opportunity By Geographical Landscape ($ million)
o Exhibit 95: Data Table on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 96: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 97: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 98: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 99: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 100: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 101: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 102: Abbott Laboratories - Overview
o Exhibit 103: Abbott Laboratories - Business segments
o Exhibit 104: Abbott Laboratories - Key news
o Exhibit 105: Abbott Laboratories - Key offerings
o Exhibit 106: Abbott Laboratories - Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 107: Becton Dickinson and Co. - Overview
o Exhibit 108: Becton Dickinson and Co. - Business segments
o Exhibit 109: Becton Dickinson and Co. - Key news
o Exhibit 110: Becton Dickinson and Co. - Key offerings
o Exhibit 111: Becton Dickinson and Co. - Segment focus
o 12.5 bioMerieux SA
o Exhibit 112: bioMerieux SA - Overview
o Exhibit 113: bioMerieux SA - Product / Service
o Exhibit 114: bioMerieux SA - Key offerings
o 12.6 Danaher Corp.
o Exhibit 115: Danaher Corp. - Overview
o Exhibit 116: Danaher Corp. - Business segments
o Exhibit 117: Danaher Corp. - Key news
o Exhibit 118: Danaher Corp. - Key offerings
o Exhibit 119: Danaher Corp. - Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 120: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 121: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 122: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 123: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 124: F. Hoffmann La Roche Ltd. - Segment focus
o 12.8 Fluxergy Inc.
o Exhibit 125: Fluxergy Inc. - Overview
o Exhibit 126: Fluxergy Inc. - Product / Service
o Exhibit 127: Fluxergy Inc. - Key offerings
o 12.9 Johnson and Johnson Services Inc.
o Exhibit 128: Johnson and Johnson Services Inc. - Overview
o Exhibit 129: Johnson and Johnson Services Inc. - Business segments
o Exhibit 130: Johnson and Johnson Services Inc. - Key news
o Exhibit 131: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 132: Johnson and Johnson Services Inc. - Segment focus
o 12.10 LifeScan IP Holdings LLC
o Exhibit 133: LifeScan IP Holdings LLC - Overview
o Exhibit 134: LifeScan IP Holdings LLC - Product / Service
o Exhibit 135: LifeScan IP Holdings LLC - Key offerings
o 12.11 Nova Biomedical Corp.
o Exhibit 136: Nova Biomedical Corp. - Overview
o Exhibit 137: Nova Biomedical Corp. - Product / Service
o Exhibit 138: Nova Biomedical Corp. - Key offerings
o 12.12 PHC Holdings Corp.
o Exhibit 139: PHC Holdings Corp. - Overview
o Exhibit 140: PHC Holdings Corp. - Business segments
o Exhibit 141: PHC Holdings Corp. - Key offerings
o Exhibit 142: PHC Holdings Corp. - Segment focus
o 12.13 Siemens AG
o Exhibit 143: Siemens AG - Overview
o Exhibit 144: Siemens AG - Business segments
o Exhibit 145: Siemens AG - Key news
o Exhibit 146: Siemens AG - Key offerings
o Exhibit 147: Siemens AG - Segment focus
o 12.14 Sinocare Inc.
o Exhibit 148: Sinocare Inc. - Overview
o Exhibit 149: Sinocare Inc. - Product / Service
o Exhibit 150: Sinocare Inc. - Key news
o Exhibit 151: Sinocare Inc. - Key offerings
o 12.15 Sysmex Corp.
o Exhibit 152: Sysmex Corp. - Overview
o Exhibit 153: Sysmex Corp. - Business segments
o Exhibit 154: Sysmex Corp. - Key offerings
o Exhibit 155: Sysmex Corp. - Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 156: Thermo Fisher Scientific Inc. - Overview
o Exhibit 157: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 158: Thermo Fisher Scientific Inc. - Key news
o Exhibit 159: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 160: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Trinity Biotech Plc
o Exhibit 161: Trinity Biotech Plc - Overview
o Exhibit 162: Trinity Biotech Plc - Product / Service
o Exhibit 163: Trinity Biotech Plc - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 164: Inclusions checklist
o Exhibit 165: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 166: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 167: Research methodology
o Exhibit 168: Validation techniques employed for market sizing
o Exhibit 169: Information sources
o 13.5 List of abbreviations
o Exhibit 170: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Europe: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ million)
Exhibits18: Historic Market Size - Data Table on poct market in Europe 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Five forces analysis - Comparison between 2022 and 2027
Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits24: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits25: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits26: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits27: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits28: Chart on Market condition - Five forces 2022 and 2027
Exhibits29: Chart on Type - Market share 2022-2027 (%)
Exhibits30: Data Table on Type - Market share 2022-2027 (%)
Exhibits31: Chart on Comparison by Type
Exhibits32: Data Table on Comparison by Type
Exhibits33: Chart on OTC testing - Market size and forecast 2022-2027 ($ million)
Exhibits34: Data Table on OTC testing - Market size and forecast 2022-2027 ($ million)
Exhibits35: Chart on OTC testing - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on OTC testing - Year-over-year growth 2022-2027 (%)
Exhibits37: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
Exhibits38: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ million)
Exhibits39: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%)
Exhibits40: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%)
Exhibits41: Market opportunity by Type ($ million)
Exhibits42: Data Table on Market opportunity by Type ($ million)
Exhibits43: Chart on Application - Market share 2022-2027 (%)
Exhibits44: Data Table on Application - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Application
Exhibits46: Data Table on Comparison by Application
Exhibits47: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Application ($ million)
Exhibits68: Data Table on Market opportunity by Application ($ million)
Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits70: Chart on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits71: Data Table on Market share By Geographical Landscape - 2022-2027 (%)
Exhibits72: Chart on Geographic comparison
Exhibits73: Data Table on Geographic comparison
Exhibits74: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits78: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits79: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits80: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits81: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits82: Chart on Italy - Market size and forecast 2022-2027 ($ million)
Exhibits83: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
Exhibits84: Chart on Italy - Year-over-year growth 2022-2027 (%)
Exhibits85: Data Table on Italy - Year-over-year growth 2022-2027 (%)
Exhibits86: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits87: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits89: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ million)
Exhibits91: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ million)
Exhibits92: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits93: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
Exhibits94: Market opportunity By Geographical Landscape ($ million)
Exhibits95: Data Table on Market opportunity By Geographical Landscape ($ million)
Exhibits96: Impact of drivers and challenges in 2022 and 2027
Exhibits97: Overview on Criticality of inputs and Factors of differentiation
Exhibits98: Overview on factors of disruption
Exhibits99: Impact of key risks on business
Exhibits100: Vendors covered
Exhibits101: Matrix on vendor position and classification
Exhibits102: Abbott Laboratories - Overview
Exhibits103: Abbott Laboratories - Business segments
Exhibits104: Abbott Laboratories - Key news
Exhibits105: Abbott Laboratories - Key offerings
Exhibits106: Abbott Laboratories - Segment focus
Exhibits107: Becton Dickinson and Co. - Overview
Exhibits108: Becton Dickinson and Co. - Business segments
Exhibits109: Becton Dickinson and Co. - Key news
Exhibits110: Becton Dickinson and Co. - Key offerings
Exhibits111: Becton Dickinson and Co. - Segment focus
Exhibits112: bioMerieux SA - Overview
Exhibits113: bioMerieux SA - Product / Service
Exhibits114: bioMerieux SA - Key offerings
Exhibits115: Danaher Corp. - Overview
Exhibits116: Danaher Corp. - Business segments
Exhibits117: Danaher Corp. - Key news
Exhibits118: Danaher Corp. - Key offerings
Exhibits119: Danaher Corp. - Segment focus
Exhibits120: F. Hoffmann La Roche Ltd. - Overview
Exhibits121: F. Hoffmann La Roche Ltd. - Business segments
Exhibits122: F. Hoffmann La Roche Ltd. - Key news
Exhibits123: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits124: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits125: Fluxergy Inc. - Overview
Exhibits126: Fluxergy Inc. - Product / Service
Exhibits127: Fluxergy Inc. - Key offerings
Exhibits128: Johnson and Johnson Services Inc. - Overview
Exhibits129: Johnson and Johnson Services Inc. - Business segments
Exhibits130: Johnson and Johnson Services Inc. - Key news
Exhibits131: Johnson and Johnson Services Inc. - Key offerings
Exhibits132: Johnson and Johnson Services Inc. - Segment focus
Exhibits133: LifeScan IP Holdings LLC - Overview
Exhibits134: LifeScan IP Holdings LLC - Product / Service
Exhibits135: LifeScan IP Holdings LLC - Key offerings
Exhibits136: Nova Biomedical Corp. - Overview
Exhibits137: Nova Biomedical Corp. - Product / Service
Exhibits138: Nova Biomedical Corp. - Key offerings
Exhibits139: PHC Holdings Corp. - Overview
Exhibits140: PHC Holdings Corp. - Business segments
Exhibits141: PHC Holdings Corp. - Key offerings
Exhibits142: PHC Holdings Corp. - Segment focus
Exhibits143: Siemens AG - Overview
Exhibits144: Siemens AG - Business segments
Exhibits145: Siemens AG - Key news
Exhibits146: Siemens AG - Key offerings
Exhibits147: Siemens AG - Segment focus
Exhibits148: Sinocare Inc. - Overview
Exhibits149: Sinocare Inc. - Product / Service
Exhibits150: Sinocare Inc. - Key news
Exhibits151: Sinocare Inc. - Key offerings
Exhibits152: Sysmex Corp. - Overview
Exhibits153: Sysmex Corp. - Business segments
Exhibits154: Sysmex Corp. - Key offerings
Exhibits155: Sysmex Corp. - Segment focus
Exhibits156: Thermo Fisher Scientific Inc. - Overview
Exhibits157: Thermo Fisher Scientific Inc. - Business segments
Exhibits158: Thermo Fisher Scientific Inc. - Key news
Exhibits159: Thermo Fisher Scientific Inc. - Key offerings
Exhibits160: Thermo Fisher Scientific Inc. - Segment focus
Exhibits161: Trinity Biotech Plc - Overview
Exhibits162: Trinity Biotech Plc - Product / Service
Exhibits163: Trinity Biotech Plc - Key offerings
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations